We are live on !
Find out more
Delek Group Portfolio holdings
AUM
$2.59B
Turnover
32.94%
1-Year Est. Return
1.24%
This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
-1.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.59B
AUM Growth
+$180M
(+7.5%)
Cap. Flow
-$12M
Cap. Flow % of AUM
Cap. Flow %
-0.46%
Top 10 Holdings %
Top 10 Hldgs %
27.3%
Holding
255
New
49
Increased
70
Reduced
72
Closed
35
Avg Time Held
Equity + Options
0.9
years
Top 10 Avg Time Held
Equity + Options
0.6
years
Top 20 Avg Time Held
Equity + Options
0.9
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0.6
years
Top 20 Avg Time Held Equity only
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$28.1M |
| 2 |
iShares US Healthcare Providers ETF
IHF
|
+$28.1M |
| 3 |
Newmont
NEM
|
+$23.7M |
| 4 |
Freeport-McMoran
FCX
|
+$22.1M |
| 5 |
Trip.com Group
TCOM
|
+$22.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$50.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$43.1M |
| 3 |
Meta Platforms (Facebook)
META
|
+$25.2M |
| 4 |
Southern Copper
SCCO
|
+$19.3M |
| 5 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$17.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26% |
| 2 | Technology | 14.15% |
| 3 | Healthcare | 11.72% |
| 4 | Industrials | 9.3% |
| 5 | Materials | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
CALL
iShares S&P 100 ETF
OEF
$20.5B
| $219M | 8.47% |
1,408,000
+1,390,500
| +7,946% | +$178M |
2019 Q1
1 quarter
|
|
|
2
PUT
iShares S&P 100 ETF
OEF
$20.5B
| $97.7M | 3.78% |
+628,000
| New | +$80.3M |
2019 Q2
0 quarters
|
|
3
The Mosaic Company
MOS
$5.7B
| $59.7M | 2.31% |
2,440,862
+505,367
| +26% | +$12.3M |
2017 Q4
6 quarters
|
|
4
Teva Pharmaceutical Industries Limited
TEVA
$48.2B
| $57.4M | 2.22% |
6,367,642
+1,230,259
| +24% | +$14.8M |
2017 Q4
6 quarters
|
|
5
Viatris
VTRS
$21B
| $51.6M | 2% |
2,775,111
-18,600
| -0.7% | -$411K |
2017 Q4
6 quarters
|
|
6
SolarEdge
SEDG
$1.91B
| $49.5M | 1.91% |
811,043
+99,236
| +14% | +$5.01M |
2017 Q4
6 quarters
|
|
7
Tower Semiconductor
TSEM
$22.7B
| $47.6M | 1.84% |
3,092,677
-344,547
| -10% | -$5.75M |
2017 Q4
6 quarters
|
|
8
Alphabet (Google) Class C
GOOG
$4.16T
| $44.2M | 1.71% |
836,320
+220,140
| +36% | +$12.7M |
2017 Q4
6 quarters
|
|
9
Check Point Software Technologies
CHKP
$14.2B
| $41.9M | 1.62% |
371,279
+81,311
| +28% | +$9.6M |
2017 Q4
6 quarters
|
|
10
Ormat Technologies
ORA
$5.33B
| $37.1M | 1.44% |
601,241
-228,368
| -28% | -$13.6M |
2017 Q4
6 quarters
|
|
11
Ovintiv
OVV
$19.4B
| $35.8M | 1.38% |
1,424,650
+300,000
| +27% | +$9.36M |
2018 Q3
3 quarters
|
|
12
Oracle
ORCL
$393B
| $32.5M | 1.26% |
584,506
+3,140
| +0.5% | +$170K |
2017 Q4
6 quarters
|
|
13
Radware
RDWR
$1.2B
| $32.5M | 1.26% |
1,343,636
+487,831
| +57% | +$12.2M |
2017 Q4
6 quarters
|
|
14
BP
BP
$127B
| $32.3M | 1.25% |
806,091
| – | – |
2017 Q4
6 quarters
|
|
15
Delek US
DK
$4.6B
| $31.2M | 1.21% |
788,721
-150,000
| -16% | -$5.49M |
2017 Q4
6 quarters
|
|
|
NBL
16
DELISTED
Noble Energy, Inc.
NBL
| $31M | 1.2% |
1,405,000
+266,844
| +23% | +$6.33M |
2017 Q4
6 quarters
|
|
|
17
iShares US Healthcare Providers ETF
IHF
$1.39B
| $30.1M | 1.16% |
897,585
+843,950
| +1,574% | +$28.1M |
2017 Q4
6 quarters
|
|
18
Wells Fargo
WFC
$246B
| $28.8M | 1.11% |
623,053
+300,000
| +93% | +$14M |
2017 Q4
6 quarters
|
|
19
Caesarstone
CSTE
$81.8M
| $27.8M | 1.07% |
1,890,409
| – | – |
2017 Q4
6 quarters
|
|
20
Nu Skin
NUS
$242M
| $27.7M | 1.07% |
573,900
+198,900
| +53% | +$10.1M |
2019 Q1
1 quarter
|
|
21
Kornit Digital
KRNT
$751M
| $27.2M | 1.05% |
880,133
-112,245
| -11% | -$3.1M |
2017 Q4
6 quarters
|
|
22
Bristol-Myers Squibb
BMY
$120B
| $27M | 1.04% |
608,325
+348,325
| +134% | +$16.2M |
2018 Q4
2 quarters
|
|
23
Vodafone
VOD
$36.8B
| $26.7M | 1.03% |
1,631,000
+400,000
| +32% | +$6.88M |
2017 Q4
6 quarters
|
|
|
24
Philip Morris
PM
$313B
| $26.4M | 1.02% |
+340,000
| New | +$28.1M |
2019 Q2
0 quarters
|
|
|
25
Newmont
NEM
$124B
| $26.3M | 1.02% |
+700,000
| New | +$23.7M |
2019 Q2
0 quarters
|
|
Similar funds
LIC
Delek Group's Q2 2019 Portfolio in Review
As of Q2 2019, Delek Group held 255 positions worth $2.59B, up 7.5% from $2.41B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Delek Group's Q2 2019 filing shows 49 new, 70 increased, 72 reduced and 35 closed positions. Its largest new stake was Philip Morris: 340,000 shares worth $26.4M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $50.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.
- Delek Group's largest Q2 2019 buy was Philip Morris: 340,000 shares worth $26.4M.
- Delek Group added most to iShares US Healthcare Providers ETF in Q2 2019, an estimated $28.1M increase.
- Delek Group's biggest Q2 2019 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $50.7M.
- Delek Group fully exited Southern Copper in Q2 2019, selling an estimated $19.3M.
- Delek Group's ten largest holdings make up 27% of its $2.59B portfolio in Q2 2019.
- Delek Group opened 49 new positions and closed 35 in Q2 2019.
- Delek Group's portfolio value rose 7.5% quarter-over-quarter to $2.59B.
Based on Delek Group's 13F filing for Q2 2019, filed 8 Aug 2019.